SearchBrenda Shanahan
Brenda Shanahan served in senior executive and board roles in Australia and overseas primarily in stockbroking, funds management and investment consulting. She is a director of Clinuvel Pharmaceuticals, Bell Financial Group, Phoslock Environment Technologies, and DMP Asset Management. She is also a member of Swinburne University Industry Advisory Board, and the Australian Advisory Board on Technology and Healthcare Competitiveness. Ms Shanahan was chair of St Vincent’s Institute of Medical Research and is a member of the SVI Foundation. She was a director of Challenger Limited, member of the Australian Stock Exchange, partner of May Mellor Laing & Cruikshank, principal of Investment Consulting, and worldwide partner at WM Mercer.
Bio last updated 27 Nov 2018
Access to our data for Brenda Shanahan is only available to paid subscribers with BNiQ access.
The BNiQ search engine is Western Australia's most accurate and comprehensive business listings and searchable database.
Brenda Shanahan is linked to 1 organisation which is included in 1 list - Philanthropic Foundations.
To see the data you will need to subscribe.
Roles
Year started and most recent title
BNiQ Disclaimer
Some of the information on ASX-listed public companies is sourced from Morningstar Australasia Pty Ltd (ABN: 95 090 665 544).
It is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
Show moreIt is important to note that the Morningstar information displayed by Business News is not to be copied or distributed except as authorised; and that such information is not warranted to be accurate, complete or timely and that neither Morningstar nor Business News are responsible for any damages or losses arising from any use of this information.
The information is general information only and does not constitute financial advice It is not intended to be, and should not be construed in any way as, investment, legal or financial advice
Retail clients should be advised the Morningstar Financial Services Guide can be found at http://www.morningstar.com.au/fsg.asp
